These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
136 related items for PubMed ID: 16682306
1. Tincture of time: when to implant a prophylactic cardioverter-defibrillator following coronary revascularization? Gillis AM. J Am Coll Cardiol; 2006 May 02; 47(9):1818-9. PubMed ID: 16682306 [No Abstract] [Full Text] [Related]
6. Prophylactic implantable cardioverter-defibrillators after myocardial infarction--not for everyone. Gillis AM. N Engl J Med; 2004 Dec 09; 351(24):2540-2. PubMed ID: 15590957 [No Abstract] [Full Text] [Related]
7. Prognostic role of post-infarction C-reactive protein in patients undergoing implantation of cardioverter-defibrillators: design of the C-reactive protein Assessment after Myocardial Infarction to GUide Implantation of DEfibrillator (CAMI GUIDE) study. Bellocci F, Biasucci LM, Gensini GF, Padeletti L, Raviele A, Santini M, Giubilato G, Landolina M, Biondi-Zoccai G, Raciti G, Sassara M, Castro A, Kheir A, Crea F. J Cardiovasc Med (Hagerstown); 2007 Apr 09; 8(4):293-9. PubMed ID: 17413310 [Abstract] [Full Text] [Related]
8. Revascularization versus implantable cardioverter-defibrillators to prevent sudden death in patients with severe left ventricular dysfunction. Weintraub WS. Circulation; 2001 Sep 25; 104(13):1457-8. PubMed ID: 11571235 [No Abstract] [Full Text] [Related]
9. Selecting patients for an implantable cardioverter-defibrillator: can the genie be put back into the bottle? Mittal S. J Am Coll Cardiol; 2008 Jan 22; 51(3):297-9. PubMed ID: 18206739 [No Abstract] [Full Text] [Related]
10. Implantable cardioverter-defibrillator therapy after acute myocardial infarction: the results are not shocking. Goldberger JJ, Passman R. J Am Coll Cardiol; 2009 Nov 24; 54(22):2001-5. PubMed ID: 19926004 [Abstract] [Full Text] [Related]
15. Risk of sudden death after discharge following myocardial infarction. Birnie DH, Cobbe SM. Eur Heart J; 2001 Jul 24; 22(14):1153-5. PubMed ID: 11440487 [No Abstract] [Full Text] [Related]
16. Mechanisms of sudden cardiac death in myocardial infarction survivors: insights from the randomized trials of implantable cardioverter-defibrillators. Bunch TJ, Hohnloser SH, Gersh BJ. Circulation; 2007 May 08; 115(18):2451-7. PubMed ID: 17485594 [No Abstract] [Full Text] [Related]
17. Implantable cardioverter defibrillators after acute myocardial infarction. Liew R. BMJ; 2010 Nov 19; 341():c5741. PubMed ID: 21097570 [No Abstract] [Full Text] [Related]
18. Application of the main implantable cardioverter-defibrillator trials and the 2006 Guidelines for Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death. Proclemer A, Ghidina M. J Cardiovasc Med (Hagerstown); 2007 May 19; 8(5):320-3. PubMed ID: 17443096 [No Abstract] [Full Text] [Related]